American Journal of HematologyVolume 70, Issue 4 p. 329-330 Letters and CorrespondenceFree Access Effective treatment with recombinant factor VIIa of severe bleeding due to acquired factor VIII inhibitor and acquired thrombocytopathy Venancio Conesa, Venancio Conesa Service of Hematology, Hospital General Universitario de Elche, Alicante, SpainSearch for more papers by this authorAngela Mompel, Angela Mompel Service of Hematology, Hospital General Universitario de Elche, Alicante, SpainSearch for more papers by this authorFrancisco López, Francisco López Service of Internal Medicine, Hospital General Universitario de Elche, Alicante, SpainSearch for more papers by this authorFRANCISCA Marín, FRANCISCA Marín Service of Hematology, Hospital General Universitario de Elche, Alicante, SpainSearch for more papers by this authorJosé RUIZ, José RUIZ Service of Hematology, Hospital General Universitario de Elche, Alicante, SpainSearch for more papers by this authorFrancisco Navarro, Francisco Navarro Service of Internal Medicine, Hospital General Universitario de Elche, Alicante, SpainSearch for more papers by this authorAmparo Gómez, Amparo Gómez Service of Hematology, Hospital General Universitario de Elche, Alicante, SpainSearch for more papers by this author Venancio Conesa, Venancio Conesa Service of Hematology, Hospital General Universitario de Elche, Alicante, SpainSearch for more papers by this authorAngela Mompel, Angela Mompel Service of Hematology, Hospital General Universitario de Elche, Alicante, SpainSearch for more papers by this authorFrancisco López, Francisco López Service of Internal Medicine, Hospital General Universitario de Elche, Alicante, SpainSearch for more papers by this authorFRANCISCA Marín, FRANCISCA Marín Service of Hematology, Hospital General Universitario de Elche, Alicante, SpainSearch for more papers by this authorJosé RUIZ, José RUIZ Service of Hematology, Hospital General Universitario de Elche, Alicante, SpainSearch for more papers by this authorFrancisco Navarro, Francisco Navarro Service of Internal Medicine, Hospital General Universitario de Elche, Alicante, SpainSearch for more papers by this authorAmparo Gómez, Amparo Gómez Service of Hematology, Hospital General Universitario de Elche, Alicante, SpainSearch for more papers by this author First published: 26 July 2002 https://doi.org/10.1002/ajh.10125Citations: 3AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat References 1Green D, Lechner KA. A survery of 215 non-haemophiliac patients with inhibitors to factor VIII. Thromb Haemost 1981; 45: 200– 203. 2Hay CR, Negrier C, Ludlam CA. The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study. Thromb Haemost 1997; 78(6): 1463– 1467. 3Shaffer LG, Phillips MD. Successful treatment of acquired hemophilia with oral immunosuppressive therapy. Ann Intern Med 1997; 127: 206– 209. 4Dykes AC, Walker ID, Lowe GD, Tait RC. Combined prednisolone and immunoglobulin treatment for acquired factor VIII inhibitors: a 2-year review. Haemophilia 2001; 7(2): 160– 163. 5Meijer K, Sieders E, Slooff MJH, Wolf JTM, Merr J. Effective treatment of severe bleeding due to acquired thrombocytopathia by single dose administration of activated recombinant factor VII. Thromb Haemost 1998; 80: 204– 205. Citing Literature Volume70, Issue4August 2002Pages 329-330 ReferencesRelatedInformation

American Journal of HematologyVolume 60, Issue 2 p. 167-168 Letters and CorrespondenceFree Access Fulminant brain lymphoid infiltration in a patient with chronic lymphocytic leukemia Venancio Conesa, Venancio Conesa Hematology Service, Hospital “General Universitari d'Elx,” Alicante, SpainSearch for more papers by this authorAngela Mompel, Angela Mompel Hematology Service, Hospital “General Universitari d'Elx,” Alicante, SpainSearch for more papers by this authorJosé Ruiz, José Ruiz Hematology Service, Hospital “General Universitari d'Elx,” Alicante, SpainSearch for more papers by this authorAmparo Gómez, Amparo Gómez Hematology Service, Hospital “General Universitari d'Elx,” Alicante, SpainSearch for more papers by this authorPascual Fernandez, Pascual Fernandez Hematology Service, Hospital “General Universitari d'Alacant,” Alicante, SpainSearch for more papers by this authorJavier Lucas, Javier Lucas Hematology Service, Hospital “General Universitari d'Alacant,” Alicante, SpainSearch for more papers by this authorIgnacio Aranda, Ignacio Aranda Pathology Service, Hospital ”General Universitari d'Alacant,“ Alicante, SpainSearch for more papers by this author Venancio Conesa, Venancio Conesa Hematology Service, Hospital “General Universitari d'Elx,” Alicante, SpainSearch for more papers by this authorAngela Mompel, Angela Mompel Hematology Service, Hospital “General Universitari d'Elx,” Alicante, SpainSearch for more papers by this authorJosé Ruiz, José Ruiz Hematology Service, Hospital “General Universitari d'Elx,” Alicante, SpainSearch for more papers by this authorAmparo Gómez, Amparo Gómez Hematology Service, Hospital “General Universitari d'Elx,” Alicante, SpainSearch for more papers by this authorPascual Fernandez, Pascual Fernandez Hematology Service, Hospital “General Universitari d'Alacant,” Alicante, SpainSearch for more papers by this authorJavier Lucas, Javier Lucas Hematology Service, Hospital “General Universitari d'Alacant,” Alicante, SpainSearch for more papers by this authorIgnacio Aranda, Ignacio Aranda Pathology Service, Hospital ”General Universitari d'Alacant,“ Alicante, SpainSearch for more papers by this author First published: 27 January 1999 https://doi.org/10.1002/(SICI)1096-8652(199902)60:2<167::AID-AJH18>3.0.CO;2-WCitations: 4AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL REFERENCES 1Cramer SC, Glaspy JA, Efird JT, Louis DN. Chronic lymphocytic leukemia and the central nervous system: a clinical and pathological study. Neurology 1996; 46: 19– 25. Medline 2James HB, Hammack JE, McDonnell SK, Tefferi A. The neurologic complications of B-cell chronic lymphocytic leukemia. Neurology 1997; 48: 407– 412. Medline 3Azzarelli B, Roessmann U. Pathogenesis of central nervous system infiltration in acute leukemia. Arch Pathol Lab Med 1997; 101: 203– 205. 4Quitt M, Bazac I, Gross B, Aghai E. Fulminant bilateral cerebellar syndrome in a patient with chronic lymphocytic leukemia. Leuk Lymphoma 1994; 15: 507– 510. Medline 5Pohar S, deMetz C, Poppema S, Hugh J. Chronic lymphocytic leukemia with CNS involvement. J Neuro-Oncol 1993; 16: 35– 37. Citing Literature Volume60, Issue2February 1999Pages 167-168 ReferencesRelatedInformation